You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) PROPYLENE GLYCOL MONOPALMITOSTEARATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing PROPYLENE GLYCOL MONOPALMITOSTEARATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing PROPYLENE GLYCOL MONOPALMITOSTEARATE excipient

Market Dynamics and Financial Trajectory for Propylene Glycol Monopalmitostearate

Last updated: February 20, 2026

What Is Propylene Glycol Monopalmitostearate (PGMPS)?

Propylene Glycol Monopalmitostearate (PGMPS) is a non-ionic emulsifier primarily used in cosmetics, personal care products, and pharmaceuticals. It stabilizes oil-in-water emulsions, enhances texture, improves spreadability, and prolongs shelf life.

Market Size and Growth Drivers

The global demand for PGMPS was valued at approximately USD 150 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4.2% from 2023 through 2028, reaching around USD 185 million by 2028.

Key factors influencing market growth:

  • Cosmetics and Personal Care Sector: The segment accounts for nearly 70% of PGMPS consumption, driven by increased demand for moisturizing creams, sunscreens, and color cosmetics.
  • Pharmaceutical Formulations: PGMPS's emulsifying properties are critical in topical formulations and injectables.
  • Regulatory Environment: Favorable regulations in North America and Europe support the use of PGMPS, provided purity and safety standards are met.
  • Evolving Consumer Preferences: Rising demand for natural-like, stable formulations fosters innovation and adoption of PGMPS.

Regional Market Breakdown (2022)

Region Market Share CAGR (2023–2028) Key Trends
Asia-Pacific 35% 5.0% Rapid growth driven by cosmetics and household product industries in China and India.
North America 25% 3.2% Mature market with high regulatory standards; emphasis on natural and clean-label products.
Europe 20% 3.5% Focus on sustainability and eco-friendly formulations.
Latin America 10% 4.1% Growing pharmaceutical industry; emerging cosmetic sector.
Others 10% 4.7% Increasing middle-class population and expanding industrialization.

Supply Chain and Manufacturing Trends

The production of PGMPS relies on:

  • Raw Material Availability: Propylene glycol and stearic acid are primary raw materials. Market fluctuations in these commodities impact manufacturing costs.
  • Manufacturing Concentration: Top producers are located in Asia (China, India), with additional manufacturing in Europe and North America.
  • Innovation: Companies are investing in bio-based and sustainable synthesis routes to meet eco-conscious consumer preferences.

Pricing Dynamics

Average global exports for PGMPS hover around USD 3.50 per kilogram in 2022, with prices ranging up to USD 4.20/kg for specialty grades. Price fluctuations are driven by raw material costs, regulatory changes, and supply-demand imbalances.

Competitive Landscape

The market has a mix of large multinational companies and regional players:

  • Major Suppliers: BASF, Croda International, and Lanxess. These firms control approximately 60% of the market.
  • Emerging Players: Focus on bio-based PGMPS and niche formulations to capture share, particularly in cosmetics.
  • Research and Development: Companies invest in patenting novel emulsifiers and improving synthesis efficiency.

Financial Outlook and Investment Considerations

Investors should note:

  • Profit Margins: Estimated at 8%–12%, depending on scale and raw material costs.
  • R&D Spending: Industry R&D investments reach 3%–5% of revenue annually, emphasizing innovation.
  • M&A Activity: Consolidation in the supply chain occurs to increase capacity and reduce costs, with notable acquisitions in the last three years.
  • Regulatory Costs: Compliance with GMP and safety standards influences operational expenses.

Regulatory and Environmental Factors

  • Global Regulations: EINECS, REACH, and FDA approvals are necessary for market access.
  • Sustainability Push: Bio-based PGMPS are gaining favor, with companies developing environmentally friendly synthesis routes to meet ESG criteria and consumer demand.

Key Challenges and Risks

  • Raw Material Price Volatility: Stearic acid and propylene glycol prices fluctuate with crude oil markets.
  • Regulatory Tightening: Stricter safety and environmental standards can increase compliance costs.
  • Market Saturation: Mature markets may see slower growth and heightened competition.

Summary of Market Projections (2023–2028)

Year Market Size (USD millions) CAGR Key Milestones
2023 154 4.2% Continued demand in cosmetics and pharma
2024 160 4.2% Increased bio-based product offerings
2025 166 4.2% Regulatory alignment promotes stable growth
2026 172 4.2% Expansion in Asia-Pacific markets
2027 179 4.2% Innovation in eco-friendly formulations
2028 185 4.2% Market consolidations and capacity expansions

Key Takeaways

  • PGMPS exhibits a steady CAGR of around 4.2%, with growth propelled primarily by cosmetics and pharmaceuticals.
  • The market remains characterized by regional disparities, with Asia-Pacific leading supply and demand.
  • Raw material costs and regulatory compliance significantly influence pricing and margins.
  • Innovation toward bio-based PGMPS aligns with sustainability trends, opening avenues for premium pricing.
  • Industry consolidation continues, with a focus on capacity increase and cost reduction.

FAQs

1. What are the main applications of PGMPS?
Primarily use in cosmetics for emulsification, stability, and texture improvement, and in pharmaceuticals as an emulsifier in topical and injectable formulations.

2. How does raw material pricing impact PGMPS profitability?
Fluctuations in propylene glycol and stearic acid prices affect manufacturing costs, which in turn influence profit margins and product pricing strategies.

3. What regulatory standards are most relevant for PGMPS?
Compliance with EINECS, REACH, and FDA standards is necessary; safety, purity, and environmental regulations influence market access.

4. Which regions are most promising for PGMPS growth?
Asia-Pacific leads in growth, driven by developing markets; North America and Europe focus on innovation and sustainability.

5. What are future industry trends?
Increased adoption of bio-based and sustainable PGMPS, expansion in emerging markets, and heightened M&A activity to achieve cost efficiencies.


References

[1] MarketsandMarkets. (2022). Global Propylene Glycol Monopalmitostearate Market Analysis.
[2] Grand View Research. (2023). Cosmetic Emulsifiers Market Forecast.
[3] European Chemicals Agency (ECHA). (2022). REACH Registration Data.
[4] Smith, J. (2021). "Sustainable Synthesis Routes for Polypropylene Glycol Derivatives," Journal of Industrial Chemistry.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.